|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 469.34 USD | -1.84% |
|
+2.77% | +3.52% |
| 03-11 | Vertex Pharmaceuticals Incorporated Presents at Barclays 28th Annual Global Healthcare Conference, Mar-11-2026 11:30 AM | |
| 03-10 | US Equity Markets Mixed Amid Volatility, Crude Oil Price Rebound | MT |
Chart calendar Vertex Pharmaceuticals Incorporated
Upcoming events on Vertex Pharmaceuticals Incorporated
| 04/05/2026 | Estimated Earnings Release Date (S&P Global Derived) - Q1 2026 | ~ 21:00 |
Past events on Vertex Pharmaceuticals Incorporated
| 12/02/2026 | Earnings release - Q4 2025 | ~ 21:00 |
| 12/02/2026 | Earnings presentation | 21:30 |
| 09/11/2025 | Information meeting | 01:00 |
| 03/11/2025 | Earnings release - Q3 2025 | ~ 21:00 |
| 03/11/2025 | Earnings presentation | 21:30 |
| 04/08/2025 | Earnings presentation | 21:30 |
| 04/08/2025 | Earnings release - Q2 2025 | ~ 21:00 |
| 14/05/2025 | Présentation aux Actionnaires / Analystes | 14:00 |
| 14/05/2025 | Annual General Meeting | 14:00 |
| 05/05/2025 | Earnings release - Q1 2025 | ~ 21:00 |
| 05/05/2025 | Earnings presentation | 21:30 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 9 869 9 861 0.08% | 11 020 10 879 1.3% | 12 001 11 982 0.16% | 13 033 | 14 339 | 15 927 |
|
EBITDA Million USD | Released Forecast Spread | 4 556 4 734 -3.75% | 903 882 2.4% | 5 473 5 588 -2.05% | 5 837 | 6 806 | 7 764 |
|
EBIT Million USD | Released Forecast Spread | 4 375 4 461 -1.94% | 696 678 2.65% | 5 263 5 349 -1.61% | 5 620 | 6 498 | 7 524 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 4 380 4 415 -0.8% | 249 289 -13.9% | 4 643 4 754 -2.32% | 5 455 | 6 381 | 7 326 |
|
Net income Million USD | Released Forecast Spread | 3 620 3 574 1.28% | -536 -419 -27.93% | 3 953 3 977 -0.61% | 4 490 | 5 147 | 5 854 |
|
EPS USD | Released Forecast Spread | 13,9 13,7 1.52% | -2,08 -1,59 -30.82% | 15,3 15,5 -1.12% | 17,5 | 20,0 | 22,3 |
| Announcement Date | 05/02/24 | 10/02/25 | 12/02/26 | - |
Quarterly results
| Fiscal Period | December | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2 646 2 665 -0.73% | 2 772 2 690 3.03% | 2 912 2 781 4.72% | 2 770 2 861 -3.17% | 2 965 2 907 2% | 3 076 3 059 0.56% | 3 190 3 175 0.48% | 3 055 | 3 215 | 3 333 | 3 448 | 3 228 | 3 423 | 3 668 | 3 787 |
|
EBITDA Million USD | Released Forecast Spread | -3 092 -3 058 -1.12% | 1 360 1 305 4.24% | 1 245 1 212 2.75% | 1 231 1 313 -6.18% | 1 377 1 336 3.09% | 1 439 1 371 4.95% | 1 426 1 486 -4.04% | 1 333 | 1 389 | 1 491 | 1 475 | 1 531 | 1 520 | 1 699 | 1 873 |
|
EBIT Million USD | Released Forecast Spread | -3 146 -3 088 -1.9% | 1 307 1 213 7.72% | 1 198 1 189 0.79% | 1 183 1 301 -9.08% | 1 325 1 290 2.74% | 1 385 1 383 0.16% | 1 370 1 471 -6.83% | 1 318 | 1 414 | 1 456 | 1 483 | 1 491 | 1 480 | 1 659 | 1 833 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3 391 -3 199 -6% | 1 224 1 114 9.87% | 1 137 1 168 -2.68% | 730 1 201 -39.18% | 1 283 1 232 4.15% | 1 299 1 333 -2.55% | 1 331 1 423 -6.48% | 1 254 | 1 360 | 1 409 | 1 450 | 1 382 | 1 476 | 1 665 | 1 858 |
|
Net income Million USD | Released Forecast Spread | -3 594 -3 322 -8.18% | 1 045 941 11.09% | 913 927 -1.47% | 646 963 -32.9% | 1 033 985 4.81% | 1 083 1 057 2.43% | 1 191 1 193 -0.13% | 1 005 | 1 130 | 1 176 | 1 211 | 1 111 | 1 150 | 1 312 | 1 486 |
|
EPS USD | Released Forecast Spread | -13,9 -12,7 -9.5% | 4,01 3,63 10.45% | 3,50 3,66 -4.27% | 2,49 3,76 -33.73% | 3,99 3,72 7.33% | 4,20 4,11 2.31% | 4,65 4,59 1.35% | 3,88 | 4,42 | 4,66 | 4,79 | 4,01 | 4,66 | 5,39 | 5,46 |
| Announcement Date | 01/08/24 | 04/11/24 | 10/02/25 | 05/05/25 | 04/08/25 | 03/11/25 | 12/02/26 | - | - | - | - | - | - | - | - |
| 16/03/2026 | Ex-dividend date - 0.85 USD | 04:00 | |
| 16/03/2026 | Annual General Meeting | 15:00 | |
| 16/03/2026 | Présentation aux Actionnaires / Analystes | 15:00 | |
| 16/03/2026 | Annual General Meeting | 15:00 | |
| 16/03/2026 | Board of Directors Meeting | Day | |
| 16/03/2026 | Earnings release - Annual 2025 | ~ 04:30 | |
| 16/03/2026 | Extraordinary General Meeting | 06:30 | |
| 16/03/2026 | Extraordinary General Meeting | 07:30 | |
| 17/03/2026 | Ex-dividend date - 1.6 DKK | 04:00 | |
| 17/03/2026 | Earnings release - Annual 2025 | 16:30 |
Past sector events for Vertex Pharmaceuticals Incorporated
| 13/03/2026 | Ex-dividend date - 0.82 USD | 04:00 | |
| 13/03/2026 | Présentation aux Actionnaires / Analystes | 01:00 | |
| 13/03/2026 | Présentation aux Actionnaires / Analystes | Day | |
| 13/03/2026 | Board of Directors Meeting | Day | |
| 13/03/2026 | Earnings presentation | Day | |
| 13/03/2026 | Earnings presentation | 14:00 | |
| 13/03/2026 | Earnings release - Annual 2025 | ~ 07:00 | |
| 13/03/2026 | Earnings presentation | Day | |
| 13/03/2026 | Extraordinary General Meeting | 07:00 | |
| 13/03/2026 | Extraordinary General Meeting | 06:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VRTX Stock
- Calendar Vertex Pharmaceuticals Incorporated
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















